谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Randomized, Open-Label, Multicenter, Phase II Study Evaluating the Efficacy and Safety of BTH1677 (1,3–1,6 Beta Glucan; Imprime PGG) in Combination with Cetuximab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

M. Thomas,P. Sadjadian,J. Kollmeier, J. Lowe,P. Mattson,J. R. Trout,M. Gargano,M. L. Patchen,R. Walsh,M. Beliveau,J. F. Marier,N. Bose,K. Gorden,F. Schneller

Investigational New Drugs（2017）

引用 48|浏览1
关键词
Immunotherapy,NSCLC,Cetuximab,Biomarker,Beta glucan
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要